Literature DB >> 16010559

Magnetic resonance imaging guided corticosteroid injection of sacroiliac joints in patients with spondylarthropathy. Are multiple injections more beneficial?

I Günaydin1, P L Pereira, J Fritz, C König, I Kötter.   

Abstract

Efficacy of a second magnetic resonance (MR) imaging guided corticosteroid injection of inflamed sacroiliac joints (SIJ) in patients with spondylarthropathy. Thirty-one patients received 50 injections in an outpatient basis. Fifteen of 31 patients who relapsed or were non-responders received a second injection. All had MR guided injection of 40 mg triamcinolone acetonide into SIJ using an open 0.2 Tesla unit. Twenty of 31 patients after the first injection, and 9 of 15 patients after the second injection reported subjective improvement, which lasted for a mean of 8.7+/-10.9 and 16.1+/-15.8 months for each group. Subchondral bone marrow edema resolved in 15 of 20 patients who reported subjective improvement, after the first injection. No complications occurred. MR guided steroid injection of SIJ is effective and safe. Since there is no exposure to radiation it could be performed many times. Repeated injections seem to be beneficial for primary non-responders and patients who relapsed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16010559     DOI: 10.1007/s00296-005-0008-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  25 in total

1.  Periarticular corticosteroid treatment of the sacroiliac joint in patients with seronegative spondylarthropathy.

Authors:  R Luukkainen; M Nissilä; E Asikainen; M Sanila; K Lehtinen; A Alanaatu; H Kautiainen
Journal:  Clin Exp Rheumatol       Date:  1999 Jan-Feb       Impact factor: 4.473

2.  Cytokine correlates of clinical response patterns to infliximab treatment of ankylosing spondylitis.

Authors:  M A Stone; U Payne; C Pacheco-Tena; R D Inman
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

3.  Corticosteroid injection of the sacroiliac joint in patients with seronegative spondylarthropathy.

Authors:  Y Maugars; C Mathis; P Vilon; A Prost
Journal:  Arthritis Rheum       Date:  1992-05

Review 4.  The epidemiology of ankylosing spondylitis.

Authors:  J T Gran; G Husby
Journal:  Semin Arthritis Rheum       Date:  1993-04       Impact factor: 5.532

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

Review 6.  Anti-tumour necrosis factor alpha therapy for ankylosing spondylitis: international experience.

Authors:  J Braun; J Sieper; M Breban; E Collantes-Estevez; J Davis; R Inman; H Marzo-Ortega; H Mielants
Journal:  Ann Rheum Dis       Date:  2002-12       Impact factor: 19.103

7.  Use of dynamic magnetic resonance imaging to detect sacroiliitis in HLA-B27 positive and negative children with juvenile arthritides.

Authors:  M Bollow; T Biedermann; J Kannenberg; S Paris; C Schauer-Petrowski; K Minden; M Schöntube; B Hamm; J Sieper; J Braun
Journal:  J Rheumatol       Date:  1998-03       Impact factor: 4.666

8.  Magnetic resonance imaging (MRI) for detection of active sacroiliitis--a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI.

Authors:  U Blum; C Buitrago-Tellez; A Mundinger; T Krause; J Laubenberger; P Vaith; H H Peter; M Langer
Journal:  J Rheumatol       Date:  1996-12       Impact factor: 4.666

9.  Infliximab in ankylosing spondylitis: a prospective observational inception cohort analysis of efficacy and safety.

Authors:  Walter P Maksymowych; Gian S Jhangri; Robert G Lambert; Cathy Mallon; Heidi Buenviaje; Ewa Pedrycz; Rolfe Luongo; Anthony S Russell
Journal:  J Rheumatol       Date:  2002-05       Impact factor: 4.666

10.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10
View more
  7 in total

Review 1.  [Inflammatory spine disease as a cause of back pain].

Authors:  T Schlossbauer; A Panteleon; C Becker-Gaab
Journal:  Radiologe       Date:  2006-06       Impact factor: 0.635

2.  CT-guided corticosteroid injection of the sacroiliac joints: quality assurance and standardized prospective evaluation of long-term effectiveness over six months.

Authors:  Christian E Althoff; Matthias Bollow; Eugen Feist; Stephan R Marticorena-Garcia; Iris Eshed; Torsten Diekhoff; Bernd Hamm; Kay Geert A Hermann
Journal:  Clin Rheumatol       Date:  2015-04-22       Impact factor: 2.980

Review 3.  MRI-guided sacroiliac joint injections in children and adults: current practice and future developments.

Authors:  Danoob Dalili; Amanda Isaac; Jan Fritz
Journal:  Skeletal Radiol       Date:  2022-08-25       Impact factor: 2.128

4.  Ultrasound guided corticosteroids sacroiliac joint injections (SIJIs) in the management of active sacroiliitis: a real-life prospective experience.

Authors:  Suhel G Al Khayyat; Giuseppe Fogliame; Stefano Barbagli; Edoardo Conticini; Marta Fabbroni; Roberto D'Alessandro; Antonio Vitale; Stefano Gentileschi; Marco Bardelli; Caterina Baldi; Salvatore Massimo Stella; Annarita Saponara; Andrea Del Chiaro; Paolo Falsetti; Luca Cantarini; Bruno Frediani
Journal:  J Ultrasound       Date:  2022-10-13

Review 5.  [Concepts of in-patient gradual diagnostics for patients with lumbar back-pain].

Authors:  R Kayser; K Mahlfeld; C E Heyde
Journal:  Orthopade       Date:  2008-04       Impact factor: 1.087

6.  Evidence-based diagnosis and treatment of the painful sacroiliac joint.

Authors:  Mark Laslett
Journal:  J Man Manip Ther       Date:  2008

7.  The Role of Sacroiliac Joint Steroid Injections in the Treatment of Axial Spondyloarthritis.

Authors:  Serdar Kokar; Önder Kayhan; Savaş Şencan; Osman Hakan Gündüz
Journal:  Arch Rheumatol       Date:  2021-01-14       Impact factor: 1.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.